Join us from 10 - 11 a.m. EST Thursday, November 17, for a complimentary webinar as our team shares their experience with selecting the right study design to address diverse evidence needs.
The clinical trial setting precludes data collection about product use and pregnancy, but once a product enters the market, real-world evidence of pregnancy outcomes is essential to providing healthcare guidance for women of childbearing age. Pre-approval planning for a pregnancy registry can ultimately speed approval and positively position your product in the marketplace.
Drawing on her extensive experience and citing real-world examples, Catherine Sigler, PhD, Executive Director, Safety, Epidemiology, Registries, and Risk Management, will explain the benefits of proactive registry design during a free webinar, “Developing Innovative Approaches to Postmarketing Safety Data Collection in Pregnant Women,” on Wednesday, February 24, at 1:30 p.m. EST.
When recruiting Alzheimer’s patients for research studies, you’re recruiting caregivers as well. In our latest blog post, we share a few strategies that have worked for our clients.
Understanding the effects of medications in pregnant women is a public health need that continues to require the highest level of services our industry can provide.
Women of childbearing age have a wide range of medical conditions that require chronic therapy such as diabetes, depression, epilepsy, and asthma. If they become pregnant, they must also face questions regarding the potential impact of their medication on the risk of birth defects.